CME pending. In the "Bridging the Gap: A Panel Discussion on Human and Animal Health" CME series, clinicans will learn about the vital connection between human and animal health in managing chronic infectious diseases, featuring experts from diverse fields.

1.0 CME. In the "Bridging the Gap: A Panel Discussion on Human and Animal Health" CME series, physicians will learn about the vital connection between human and animal health in managing chronic infectious diseases, featuring experts from diverse fields.

CME pending. This course explores the multiple hits model of illness, the overlapping symptomatology of Borrelia and Bartonella infections, and the limitations of diagnostic testing for these conditions. It also hypothesizes how PANDAS/PANS symptoms might result from a wide variety of triggers, both infectious and non-infectious.

0.5 CME. In Pathogenic Bacteria Carried by Cat Fleas, medical professionals are provided with comprehensive knowledge about the risks associated with infections transmitted by cat fleas.

Dr. D. Scott Smith leads the new CME course "Rocky Mountain Spotted Fever" which provides comprehensive insights into diagnosing and treating this severe tick-borne disease.

1.5 CME. This panel aims to equip clinicians with the latest insights and evidence-based strategies for managing two challenging conditions: long COVID and long Lyme disease.

0.5 CME. This course, "Antibiotic Treatment of Bartonella Infections", taught by Dr. Monica Embers, is an educational resource for clinicians to enhance understanding and treatment approaches for Bartonella infections.

0.5 CME. This course by Dr. Shannon Delaney, a Columbia-trained psychiatrist physician, illuminates key insights from her study "Borrelia miyamotoi Serology in a Clinical Population With Persistent Symptoms and Suspected Tick-Borne Illness.” 

0.5 CME. This module discusses differences between antibiotic tolerance and resistance in Lyme disease, demonstrates persistence via tolerance by the Lyme disease spirochete, and evaluates the efficacy of combination therapy versus monotherapy in both animal models and humans.

0.5 CME. The course addresses Leptospirosis as a global threat that frequently mimics diseases like Lyme disease. It is designed to improve healthcare providers' ability to identify the often non-specific symptoms of Leptospirosis, a challenge in its early detection.

0.25 CME. This course uses two illustrative cases and CDC surveillance case data to discuss racial/ethnic health inequities and disparities in Lyme disease. It also discusses the role of improved clinician education in reducing known health disparities.

0.25 CME. This course teaches how to diagnose and treat infections caused by babesia, a malaria-like protozoan parasite that can be transmitted through tick bites, blood transfusions, and organ transplants, or congenitally from mother to fetus. The course also discusses the global distribution of babesia and a new species of babesia, B. odocoilei, which may be causing unrecognized disease.

0.25 CME. This course gives an overview of a 2022 study that measured high-sensitivity troponin T in patients with early Lyme disease, and demonstrates that the causative bacteria of Lyme disease, Borrelia burgdorferi, may cause abnormal issues to the heart more often than previously thought, affecting 14.6% of these patients in the study.

1.0 CME. This course provides an overview of the One Health framework and describes how it can be applied in clinical practice. This framework recognizes that the health of people, animals, and the environment are inextricably interconnected. The course uses Lyme disease to illustrate this approach, drawing on relevant peer-reviewed studies on clinical strategies.

1.0 CME. This course will provide an introduction to the zoonotic diseases that can be carried and transmitted by pet cats, as well as an introduction to diseases that are important to consider with cat adoption and relocation. Finally an overview of disease prevention methods will be presented.

0.75 CME. This course is intended to help clinicians be aware of the mental health needs and risks in patients with Lyme disease and educates on appropriate professional mental health referral, based on symptoms and clinical presentation. This concise, data-driven overview will help clinicians quickly access the latest evidence on Lyme disease persistence after standard treatments, useful in overturning the long-held belief that Lyme disease is always easy to treat and cure.

0.25 CME. In the first study of its kind, two Lyme disease experts gathered data on a question frequently asked by tick-borne disease patients: Why is it so hard to find a Lyme-treating physician, when the need is so great? There are 476,000 new Lyme cases annually, reported from all 50 states, per the CDC. This course answers these questions based on data from a survey of 155 clinicians from 30 states who treat Lyme patients. The study’s goal was to identify the problems that clinicians face when treating these patients, a first step to overcoming these obstacles.

0.75 CME. This course will provide an introduction to the zoonotic diseases that can be carried and transmitted by pet dogs, as well as an introduction to diseases that may be imported during international dog adoption. The role of dogs as sentinels and clinical models for zoonotic diseases will be covered. Finally an overview of disease prevention methods will be presented.

0.5 CME. This module presents the most commonly used tests to diagnose Lyme disease, describes their deficiencies, and provides clinicians with important findings regarding the variability in immune responses among infected individuals. How to interpret the two-tier test, especially the western blot, is discussed in detail and in conjunction with the research findings on immune response differences. Finally, the needs and challenges for new diagnostic modalities are considered.